|
Market Closed -
Euronext Paris
20:55:00 26/10/2026 +04
|
After hours 00:12:19 | |||
| 1.302 EUR | +0.62% |
|
1.297 | -0.38% |
| 10-09 | Lannebo Sverige fell 0.9 percent in September, forestry companies performed well | FW |
| 09-21 | Innate Pharma S.A.(ENXTPA:IPH) added to S&P Global BMI Index | CI |
| Market Cap | 122M 136M 113M 102M 191M 12.98B 194M 1.36B 537M 6.79B 512M 501M 21.5B | P/E 2026 * |
2.71x | P/E 2027 * | 0.6x |
|---|---|---|---|---|---|
| Enterprise Value | 23.9M 26.73M 22.11M 20.02M 37.47M 2.54B 38.08M 266M 105M 1.33B 100M 98.16M 4.21B | EV / Sales 2026 * |
0.54x | EV / Sales 2027 * | -1.63x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IPH | Real-time | |
CBOE
| IPHp | Real-time | |
|
Börse Stuttgart
| IDD | Delayed | |
|
OTC Markets
| IPHYF | Delayed | |
|
Tradegate
| IDD | Real-time | |
|
Deutsche Boerse AG
| IDD | Delayed | |
|
Xetra
| IDD | Delayed | |
|
London S.E.
| 0EVI | Delayed | |
|
CBOE
| 0EVI | Real-time | |
|
Boerse Muenchen
| IDD | Real-time | |
|
Borsa Italiana
| 4IPH | End-of-day quote |
Last Transcript: Innate Pharma
| 1 day | +0.62% | ||
| Current month | -7.13% | ||
| 1 month | -9.71% | ||
| 3 months | -18.01% | ||
| 6 months | +16.25% | ||
| Current year | -18.73% |
| 1 week | 1.26 |  | 1.38 |
| 1 month | 1.24 | | 1.47 |
| Current year | 1.03 | | 2.33 |
| 1 year | 1.03 | | 2.33 |
| 3 years | 1.03 | | 2.8 |
| 5 years | 1.03 | | 5.26 |
| 10 years | 1.03 | | 15.83 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 01/11/2024 | |
Frederic Lombard
DFI | Director of Finance/CFO | 51 | 01/04/2021 |
Markus Jensen
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 01/01/2024 | |
| Director/Board Member | 64 | 27/04/2015 | |
Pascale Boissel
BRD | Director/Board Member | 60 | 19/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/08/26 | BPIFrance Participations SA /PRIVATE EQUITY/
| Buy | Company | 1,764,705 | 1.8789% | |
| 20/01/26 | Buy | Executive/Senior Manager | 50,000 | 0.0542% | ||
| 16/01/26 | Buy | Chief Financial Officer | 50,000 | 0.0542% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.62% | 0.00% | -29.62% | -44.60% | 136M | |
| +0.88% | +1.18% | +40.64% | +74.91% | 64.69B | |
| -0.26% | +7.23% | +11.14% | +74.78% | 54.78B | |
| +0.47% | +5.10% | +8.22% | +101.52% | 53.49B | |
| -2.06% | +2.51% | +24.07% | +50.98% | 45.98B | |
| -1.79% | +0.49% | +19.32% | +122.77% | 42.94B | |
| -1.65% | +3.34% | +237.56% | +819.04% | 40.08B | |
| -2.26% | -2.06% | +15.38% | +45.14% | 33.52B | |
| +0.22% | -4.77% | +26.59% | +0.55% | 23.97B | |
| +12.10% | +18.47% | +55.14% | +45.58% | 23.67B | |
| Average | +0.63% | +1.94% | +40.84% | +129.07% | 38.32B | |
| Weighted average by Cap. | +0.12% | +2.59% | +45.90% | +149.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 44.17M 49.4M 40.87M 37M 69.26M 4.7B 70.39M 492M 195M 2.46B 185M 181M 7.78B | 107M 120M 99.34M 89.94M 168M 11.42B 171M 1.2B 473M 5.98B 451M 441M 18.92B |
| Net income | -8.91M -9.97M -8.25M -7.47M -13.97M -948M -14.2M -99.22M -39.25M -496M -37.41M -36.61M -1.57B | 25.08M 28.05M 23.2M 21.01M 39.32M 2.67B 39.96M 279M 110M 1.4B 105M 103M 4.42B |
| Net Debt | -98.1M -110M -90.76M -82.18M -154M -10.44B -156M -1.09B -432M -5.46B -412M -403M -17.29B | -297M -332M -275M -249M -466M -31.62B -474M -3.31B -1.31B -16.54B -1.25B -1.22B -52.37B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | €1.302 | +0.62% | 187,593 |
| 23/10/26 | €1.294 | -0.77% | 64,222 |
| 22/10/26 | €1.304 | -3.26% | 75,418 |
| 21/10/26 | €1.348 | -0.15% | 214,008 |
| 20/10/26 | €1.350 | +6.64% | 200,404 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPH Stock
Select your edition
All financial news and data tailored to specific country editions
